Literature DB >> 26451757

Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Silvia S Martins, Laura Sampson, Magdalena Cerdá, Sandro Galea.   

Abstract

BACKGROUND: Drug overdose is an important, yet an inadequately understood, public health problem. Global attention to unintentional drug overdose has been limited by comparison with the scope of the problem. There has been a substantial increase in drug overdose incidence and prevalence in several countries worldwide over the past decade, contributing to both increased costs and mortality.
OBJECTIVES: The aim of this study was to systematically synthesize the peer-reviewed literature to document the global epidemiological profile of unintentional drug overdoses and the prevalence, time trends, mortality rates, and correlates of drug overdoses. We searched different combinations of Medical Subject Headings (MeSH) terms in PubMed for articles published from 1980 until July 2013, and we organized these results in tabular spreadsheets and compared them. We restricted the search to English-language articles that deal with unintentional overdose, focusing on 1 or more of the following key constructs: prevalence, time trends, mortality rates, and correlates. The term "overdose" as a MeSH major topic yielded 1076 publications. In addition, we searched the following combinations of nonmajor MeSH terms: "street drugs" and "overdose" yielded 180, "death" and "overdose" yielded 114, and "poisoning" and "drug users" yielded 17. There was some overlap among the searches. Based on the search and inclusion and exclusion criteria, we selected a total of 169 relevant articles for this article based on a close review of abstracts.
RESULTS: We found wide variability in lifetime prevalence of experiencing a nonfatal overdose or witnessing an overdose, and in mortality rates attributable to overdose. Lifetime prevalence of witnessed overdose among drug users (n = 17 samples) ranged from 50% to 96%, with a mean of 73.3%, a median of 70%, and a standard deviation of 14.1%. Lifetime prevalence of drug users personally experiencing a nonfatal overdose (n = 27 samples), ranged from 16.6% to 68.0% with a mean of 45.4%, a median of 47%, and a standard deviation of 14.4%. Population-based crude overdose mortality rates (n = 28 samples) ranged from 0.04 to 46.6 per 100 000 person-years. This range is likely attributable to the diversity in regions, time periods, and samples. Most studies on longitudinal trends of overdose death rates or overdose-related hospitalization rates showed increases in overdose death rates and in overdose-related hospitalization rates across time, which have led to peaks in these rates at the present time. An overall trend of increasing deaths from prescription opioid use and decreasing deaths from illicit drug use in the past several years has been noted across most of the literature. With the increase in prescription opioid overdose deaths, drug overdose is not just an urban problem: rural areas have seen an important increase in overdose deaths. Lastly, cocaine, prescription opioids, and heroin are the drugs most commonly associated with unintentional drug overdoses worldwide and the demographic and psychiatric correlates associated with unintentional drug overdoses are similar globally.
CONCLUSIONS: There is a need to invest in research to understand the distinct determinants of prescription drug overdose worldwide. Several other countries need to collect in a systematic and continuous fashion such data on sales of prescription opioids and other prescription drugs, nonmedical use of prescription drugs, and hospitalization secondary to overdoses on prescription drugs. The sparse evidence on the environmental determinants of overdose suggests a need for research that will inform the types of environmental interventions we can use to prevent drug overdose. Methodological issues for future studies include enhancing data collection methods on unintentional fatal and nonfatal overdoses, and collecting more detailed information on drug use history, source of drug use (for prescription drugs), and demographic and psychiatric history characteristics of the individual who overdosed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26451757      PMCID: PMC4605171          DOI: 10.2105/AJPH.2015.302843a

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  16 in total

1.  Association between process measures and mortality in individuals with opioid use disorders.

Authors:  Katherine E Watkins; Susan M Paddock; Teresa J Hudson; Songthip Ounpraseuth; Amy M Schrader; Kimberly A Hepner; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2017-06-27       Impact factor: 4.492

2.  Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.

Authors:  Tomás Barry; Jan Klimas; Helen Tobin; Mairead Egan; Gerard Bury
Journal:  Br J Gen Pract       Date:  2017-02-28       Impact factor: 5.386

3.  Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose.

Authors:  Rachel E Gicquelais; Mary Jannausch; Amy S B Bohnert; Laura Thomas; Srijan Sen; Anne C Fernandez
Journal:  Drug Alcohol Depend       Date:  2020-05-16       Impact factor: 4.492

4.  The relationship between parental heavy drinking and non-fatal overdose among people who inject drugs in Vancouver, Canada.

Authors:  Amy Prangnell; Ekaterina Nosova; M-J Milloy; Evan Wood; Kanna Hayashi
Journal:  Addict Behav       Date:  2018-08-15       Impact factor: 3.913

5.  Association of Injection Practices and Overdose With Drug Use Typologies: A Latent Class Analysis Among People Who Inject Drugs in Baltimore, 2017.

Authors:  Rachel E Gicquelais; Becky L Genberg; Jacquie Astemborski; David D Celentano; Gregory D Kirk; Shruti H Mehta
Journal:  AIDS Educ Prev       Date:  2019-08

6.  High occurrence of witnessing an opioid overdose in a sample of women who use heroin in Tanzania: Implications for overdose prevention.

Authors:  Haneefa T Saleem; Samuel Likindikoki; Bareng A S Nonyane; Jessie Mbwambo; Carl Latkin
Journal:  Int J Drug Policy       Date:  2021-05-14

7.  Identifying pathways to recent non-fatal overdose among people who use opioids non-medically: How do psychological pain and unmet mental health need contribute to overdose risk?

Authors:  Catherine Tomko; Kristin E Schneider; Saba Rouhani; Glenna J Urquhart; Ju Nyeong Park; Miles Morris; Susan G Sherman
Journal:  Addict Behav       Date:  2021-12-20       Impact factor: 4.591

Review 8.  From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks.

Authors:  Nikolai Jaschke; Sophie Pählig; Ying-Xian Pan; Lorenz C Hofbauer; Andy Göbel; Tilman D Rachner
Journal:  Trends Endocrinol Metab       Date:  2021-03-03       Impact factor: 12.015

9.  Prevalence and Trends of Opioid Use in Patients With Depression in the United States.

Authors:  Terence Tumenta; Derek F Ugwendum; Muchi Ditah Chobufo; Etaluka Blanche Mungu; Irina Kogan; Tolulope Olupona
Journal:  Cureus       Date:  2021-05-28

10.  Predicting the Future Course of Opioid Overdose Mortality: An Example From Two US States.

Authors:  Natalie Sumetsky; Christina Mair; Katherine Wheeler-Martin; Magdalena Cerda; Lance A Waller; William R Ponicki; Paul J Gruenewald
Journal:  Epidemiology       Date:  2021-01       Impact factor: 4.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.